European Association for the Study of Diabetes
@easdnews.bsky.social
We promote excellence in #diabetes #care through #research, #networking and #education.
The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965, headquartered in Germany
The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965, headquartered in Germany
🚶♀️Can #GLP1RA help people living with #T2D and #PAD walk farther without pain?
Assoc. Prof. Alice Cheng discusses the #STRIDE trial results & why PAD deserves more attention in #diabetescare in our latest EASD e-Learning #ExpertInsights episode.
📺🔗 Watch now: easd-elearning.eu/episode/354/...
Assoc. Prof. Alice Cheng discusses the #STRIDE trial results & why PAD deserves more attention in #diabetescare in our latest EASD e-Learning #ExpertInsights episode.
📺🔗 Watch now: easd-elearning.eu/episode/354/...
November 19, 2025 at 10:34 AM
🚶♀️Can #GLP1RA help people living with #T2D and #PAD walk farther without pain?
Assoc. Prof. Alice Cheng discusses the #STRIDE trial results & why PAD deserves more attention in #diabetescare in our latest EASD e-Learning #ExpertInsights episode.
📺🔗 Watch now: easd-elearning.eu/episode/354/...
Assoc. Prof. Alice Cheng discusses the #STRIDE trial results & why PAD deserves more attention in #diabetescare in our latest EASD e-Learning #ExpertInsights episode.
📺🔗 Watch now: easd-elearning.eu/episode/354/...
A limitless supply of insulin-producing beta cells?
In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.
📺👉 Watch now: easd-elearning.eu/episode/346/...
In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.
📺👉 Watch now: easd-elearning.eu/episode/346/...
November 12, 2025 at 1:03 PM
A limitless supply of insulin-producing beta cells?
In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.
📺👉 Watch now: easd-elearning.eu/episode/346/...
In this new #ExpertInsights episode, Prof. Matthias Hebrok explains how researchers around the world are working on making #StemCellDerivedIslets work to reshape #T1D care.
📺👉 Watch now: easd-elearning.eu/episode/346/...
❓Can #socialmedia improve #diabetes care? ❓
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...
November 5, 2025 at 2:50 PM
❓Can #socialmedia improve #diabetes care? ❓
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...
Marc Evans explores its potential - along with #AI, precision prescribing & drug value of #metformin vs #SGLT2inhibitors - in the latest episode of '5 things we don't yet know about diabetes'.
📺Watch here: easd-elearning.eu/episode/351/...